Tscan Therapeutics Stock Price History
| TCRX Stock | USD 4.77 0.13 2.80% |
If you're considering investing in Tscan Stock, it is important to understand the factors that can impact its price. As of today, the current price of Tscan Therapeutics stands at 4.77, as last reported on the 29th of November, with the highest price reaching 4.82 and the lowest price hitting 4.65 during the day. Tscan Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0343, which indicates the firm had a -0.0343% return per unit of risk over the last 3 months. Tscan Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Tscan Therapeutics' Variance of 13.44, risk adjusted performance of (0.03), and Coefficient Of Variation of (2,324) to confirm the risk estimate we provide.
At this time, Tscan Therapeutics' Issuance Of Capital Stock is fairly stable compared to the past year. Stock Based Compensation To Revenue is likely to rise to 0.36 in 2024, whereas Total Stockholder Equity is likely to drop slightly above 77.3 M in 2024. . At this time, Tscan Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.09 in 2024, whereas Price To Sales Ratio is likely to drop 17.26 in 2024. Tscan Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Tscan |
Sharpe Ratio = -0.0343
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TCRX |
Estimated Market Risk
| 3.7 actual daily | 32 68% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Tscan Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tscan Therapeutics by adding Tscan Therapeutics to a well-diversified portfolio.
Price Book 1.1113 | Enterprise Value Ebitda 0.3916 | Price Sales 27.1927 | Shares Float 31.1 M | Wall Street Target Price 12.5714 |
Tscan Therapeutics Stock Price History Chart
There are several ways to analyze Tscan Stock price data. The simplest method is using a basic Tscan candlestick price chart, which shows Tscan Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 7, 2024 | 5.94 |
| Lowest Price | November 21, 2024 | 3.94 |
Tscan Therapeutics November 29, 2024 Stock Price Synopsis
Various analyses of Tscan Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Tscan Stock. It can be used to describe the percentage change in the price of Tscan Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Tscan Stock.| Tscan Therapeutics Price Rate Of Daily Change | 1.03 | |
| Tscan Therapeutics Price Daily Balance Of Power | 0.76 | |
| Tscan Therapeutics Price Action Indicator | 0.10 |
Tscan Therapeutics November 29, 2024 Stock Price Analysis
Tscan Stock Price History Data
The price series of Tscan Therapeutics for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 has a statistical range of 2.0 with a coefficient of variation of 9.12. The price distribution for the period has arithmetic mean of 5.22. The median price for the last 90 days is 5.35. The company had dividends distributed to its stock-holders on September 13, 2018.| Open | High | Low | Close | Volume | ||
11/29/2024 | 4.66 | 4.82 | 4.65 | 4.77 | ||
| 11/27/2024 | 4.66 | 4.82 | 4.65 | 4.77 | 130,587 | |
| 11/26/2024 | 4.50 | 4.77 | 4.41 | 4.64 | 166,119 | |
| 11/25/2024 | 4.36 | 4.72 | 4.30 | 4.52 | 192,247 | |
| 11/22/2024 | 3.94 | 4.30 | 3.93 | 4.26 | 181,927 | |
| 11/21/2024 | 4.13 | 4.17 | 3.92 | 3.94 | 235,480 | |
| 11/20/2024 | 4.19 | 4.23 | 4.03 | 4.12 | 165,472 | |
| 11/19/2024 | 4.12 | 4.26 | 4.07 | 4.21 | 205,735 | |
| 11/18/2024 | 4.42 | 4.43 | 4.11 | 4.20 | 169,404 | |
| 11/15/2024 | 4.85 | 4.85 | 4.31 | 4.41 | 244,070 | |
| 11/14/2024 | 5.30 | 5.30 | 4.81 | 4.82 | 166,315 | |
| 11/13/2024 | 5.44 | 5.56 | 5.25 | 5.25 | 112,041 | |
| 11/12/2024 | 5.75 | 5.75 | 5.31 | 5.42 | 323,219 | |
| 11/11/2024 | 5.89 | 5.92 | 5.67 | 5.70 | 251,901 | |
| 11/08/2024 | 5.99 | 6.04 | 5.67 | 5.78 | 176,397 | |
| 11/07/2024 | 5.75 | 6.23 | 5.72 | 5.94 | 530,458 | |
| 11/06/2024 | 5.60 | 5.75 | 5.03 | 5.69 | 1,136,277 | |
| 11/05/2024 | 5.10 | 5.98 | 5.07 | 5.29 | 553,690 | |
| 11/04/2024 | 5.01 | 5.08 | 4.84 | 5.08 | 101,841 | |
| 11/01/2024 | 4.61 | 5.10 | 4.54 | 4.95 | 222,728 | |
| 10/31/2024 | 4.73 | 4.81 | 4.53 | 4.54 | 225,273 | |
| 10/30/2024 | 4.74 | 4.85 | 4.68 | 4.73 | 154,246 | |
| 10/29/2024 | 4.87 | 4.90 | 4.61 | 4.75 | 167,743 | |
| 10/28/2024 | 4.95 | 5.04 | 4.88 | 4.89 | 111,201 | |
| 10/25/2024 | 4.99 | 5.02 | 4.85 | 4.86 | 183,963 | |
| 10/24/2024 | 5.10 | 5.14 | 4.96 | 4.97 | 65,800 | |
| 10/23/2024 | 5.21 | 5.36 | 5.07 | 5.09 | 173,548 | |
| 10/22/2024 | 5.25 | 5.38 | 5.17 | 5.24 | 83,477 | |
| 10/21/2024 | 5.37 | 5.41 | 5.16 | 5.27 | 247,139 | |
| 10/18/2024 | 5.26 | 5.39 | 5.16 | 5.37 | 87,564 | |
| 10/17/2024 | 5.54 | 5.54 | 5.21 | 5.26 | 169,314 | |
| 10/16/2024 | 5.59 | 5.68 | 5.47 | 5.51 | 241,954 | |
| 10/15/2024 | 5.50 | 5.65 | 5.28 | 5.53 | 113,569 | |
| 10/14/2024 | 5.39 | 5.60 | 5.35 | 5.55 | 125,588 | |
| 10/11/2024 | 5.33 | 5.40 | 5.26 | 5.39 | 125,725 | |
| 10/10/2024 | 5.56 | 5.57 | 5.22 | 5.35 | 229,767 | |
| 10/09/2024 | 5.58 | 5.67 | 5.51 | 5.61 | 179,660 | |
| 10/08/2024 | 5.50 | 5.68 | 5.46 | 5.59 | 147,863 | |
| 10/07/2024 | 5.51 | 5.51 | 5.33 | 5.50 | 155,188 | |
| 10/04/2024 | 5.39 | 5.55 | 5.26 | 5.51 | 287,661 | |
| 10/03/2024 | 5.21 | 5.31 | 5.12 | 5.28 | 116,304 | |
| 10/02/2024 | 4.96 | 5.26 | 4.72 | 5.24 | 232,797 | |
| 10/01/2024 | 4.95 | 5.05 | 4.84 | 4.98 | 198,328 | |
| 09/30/2024 | 5.05 | 5.27 | 4.93 | 4.98 | 630,773 | |
| 09/27/2024 | 4.99 | 5.08 | 4.90 | 5.04 | 170,490 | |
| 09/26/2024 | 5.07 | 5.11 | 4.93 | 4.97 | 163,509 | |
| 09/25/2024 | 5.17 | 5.43 | 5.00 | 5.02 | 233,221 | |
| 09/24/2024 | 5.18 | 5.21 | 5.00 | 5.10 | 234,005 | |
| 09/23/2024 | 5.50 | 5.50 | 5.13 | 5.20 | 178,006 | |
| 09/20/2024 | 5.62 | 5.62 | 5.44 | 5.52 | 345,305 | |
| 09/19/2024 | 5.78 | 5.82 | 5.47 | 5.64 | 152,254 | |
| 09/18/2024 | 5.45 | 5.79 | 5.43 | 5.54 | 302,216 | |
| 09/17/2024 | 5.78 | 5.78 | 5.45 | 5.45 | 102,825 | |
| 09/16/2024 | 5.77 | 5.92 | 5.69 | 5.74 | 212,844 | |
| 09/13/2024 | 5.63 | 5.78 | 5.55 | 5.74 | 192,256 | |
| 09/12/2024 | 5.72 | 5.72 | 5.51 | 5.54 | 130,131 | |
| 09/11/2024 | 5.87 | 5.87 | 5.63 | 5.69 | 132,388 | |
| 09/10/2024 | 5.88 | 6.04 | 5.76 | 5.92 | 196,639 | |
| 09/09/2024 | 5.57 | 6.00 | 5.38 | 5.87 | 209,849 | |
| 09/06/2024 | 5.62 | 5.72 | 5.47 | 5.55 | 216,785 | |
| 09/05/2024 | 5.61 | 5.76 | 5.57 | 5.63 | 240,704 |
About Tscan Therapeutics Stock history
Tscan Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tscan is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tscan Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tscan Therapeutics stock prices may prove useful in developing a viable investing in Tscan Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 65.6 M | 36 M | |
| Net Loss | -59.6 M | -62.6 M |
Tscan Therapeutics Quarterly Net Working Capital |
|
Tscan Therapeutics Stock Technical Analysis
Tscan Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Tscan Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Tscan Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Tscan Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tscan to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.44) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (0.07) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Tscan Stock Analysis
When running Tscan Therapeutics' price analysis, check to measure Tscan Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tscan Therapeutics is operating at the current time. Most of Tscan Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tscan Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tscan Therapeutics' price. Additionally, you may evaluate how the addition of Tscan Therapeutics to your portfolios can decrease your overall portfolio volatility.